"At the end of the first quarter, the social security fund held multiple concept stocks of innovative drugs."

Many innovative pharmaceutical concept stocks are favored by the social security fund. Statistics show that a total of 15 stocks received heavy positions from the social security fund in the first quarter report this year, with a total holding value of 4.102 billion yuan, of which 6 stocks were newly added to the fund's heavy positions in the first quarter. WuXi Biologics, Tasly Pharmaceutical, and Zaijing Pharmaceutical-U are among the top holdings by the social security fund, with holding values of 555 million yuan, 488 million yuan, and 475 million yuan respectively.